Cambridge Innovation Capital (CIC) is a venture capital investor established by the University of Cambridge (University) in 2013. Our goal is to enable visionaries to build global, category-leading life sciences and technology companies in the Cambridge ecosystem. CIC is a preferred investor for the University and the University is our largest shareholder. CIC’s first fund of £275 million has a portfolio of 31 companies and is generating strong performance. We are now in the process of raising a second fund targeted at £200 million.

EQT is a leading alternative investments firm with approximately EUR 80 billion in raised capital across more than 30 funds. EQT funds have portfolio companies in Europe, Asia and the US with total sales of more than EUR 19 billion and approximately 110,000 employees. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership. EQT is a leading alternative investments firm with approximately EUR 80 billion in raised capital across more than 30 funds. EQT funds have portfolio companies in Europe, Asia and the US with total sales of more than EUR 19 billion and approximately 110,000 employees. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership.

IdeKapital is a prominent Norwegian venture capital fund, fueling innovation and growth in the country's startup ecosystem with a strong focus on early-stage technology startups across diverse industries. With a hands-on approach and a substantial fund size, IdeKapital actively engages with portfolio companies, offering mentorship, expertise, and strategic guidance to drive sustainable growth and market leadership. Backed by an experienced team and an extensive network, the fund strategically invests in disruptive ventures, contributing significantly to Norway's reputation as a hub for technological advancement and entrepreneurial excellence.